Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin versus unfractionated heparin during PCI with drug-eluting stents
IRCT138710101525N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2004
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin, heparin in coronary arteriosclerosis, acute coronary syndrome (ACS), angina pectoris, sponsored by Shiraz University of Medical Sciences. Started Oct 2004; status: completed.
02
Drugs
enoxaparinheparin
03
Conditions
coronary arteriosclerosisacute coronary syndrome (ACS)angina pectoris
Beyond the preview
Go deeper on IRCT138710101525N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138710101525N1.